Plant-based compounds could treat chronic pain in Parkinson’s, study finds

News

Author: Sophie BatesPublished: 12 March 2020

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

A six-year study has found that chronic pain in people with Parkinson’s is linked to a gene involved with how the brain responds to cannabis compounds.  

The investigation examined why some people with the condition experience persistent pain – and the impact it has on their work, daily life and social relationships. Conducted by researchers at Manchester’s Salford Royal Foundation Trust, UK, and funded by Parkinson’s UK, it is the largest study to investigate chronic pain in people with Parkinson’s.

Dr Monty Silverdale, consultant neurologist at Greater Manchester Centre, said: “This study is significant because it shows the important role of genetics in chronic pain in Parkinson’s.

“Our findings suggest that cannabis-based compounds may be worth investigating as a treatment for pain in Parkinson’s.”


Read more: 

 Could playing table tennis help reduce Parkinson’s symptoms?

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Go Back

Share this story

Comments


Related articles


FacePrint

Interviews

“I want to create technologies that help alleviate human suffering”

Meet the 18-year-old inventor behind an award-winning Parkinson’s tool

READ MORE
brain-stem-cell-surgery

Advances

Researchers carry out ‘world-first’ stem cell treatment for Parkinson’s disease

Revolutionary stem cells injected into brain of Parkinson’s patient

READ MORE

Recipes & Nutrition

Recipe: Sweet potato mash with fennel and carrot

This nutritious recipe is tasty and easy to swallow

READ MORE